Decagon reports 5.52% stake in Oaktree Acquisition
Decagon Asset Management LLP and Benjamin John Durham report beneficial ownership of Class A ordinary shares of Oaktree Acquisition Corp. III Life Sciences.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Decagon Asset Management LLP and Benjamin John Durham report beneficial ownership of Class A ordinary shares of Oaktree Acquisition Corp. III Life Sciences. They collectively hold 1,091,327 shares, representing 5.52% of the outstanding Class A shares. They report sole voting and sole dispositive power over all 1,091,327 shares, with no shared voting or dispositive power.
Key Figures
Key Terms
beneficially owned financial
sole voting power financial
dispositive power financial
Schedule 13G regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
Who are the reporting persons on this Schedule 13G for OACC?
What type of security in OACC is reported on this Schedule 13G?
AI-generated analysis. How Rhea-AI works. Not financial advice.